A Study on the Pharmacokinetics of Chlorzoxazone in Healthy Thai VolunteersPROMPILA, Nantaporn; WITTAYALERTPANYA, Supeecha; KOMOLMIT, Piyawat et al.Chot Mai Het Thang Phaet. 2007, Vol 90, Num 1, pp 160-166, issn 0125-2208, 7 p.Article

Chlorzoxazone as a Cause of Acute Liver Failure Requiring Liver TransplantationJACKSON, James; ANANIA, Frank A.Digestive diseases and sciences. 2007, Vol 52, Num 12, pp 3389-3391, issn 0163-2116, 3 p.Article

In vivo CYP2E1 phenotyping as a new potential biomarker of occupational and experimental exposure to benzenePICCOLI, P; CARRIERI, M; PADOVANO, L et al.Toxicology letters. 2010, Vol 192, Num 1, pp 29-33, issn 0378-4274, 5 p.Conference Paper

Simultaneous determination of paracetamol, chlorzoxazone, and related impurities 4-aminophenol, 4'-chloroacetanilide, and p-chlorophenol in pharmaceutical preparations by high-performance liquid chromatographyMOHAMMED SHAHID ALI; RAFIUDDIN, Syed; GHORI, Mohsin et al.Journal of AOAC International. 2007, Vol 90, Num 1, pp 82-93, issn 1060-3271, 12 p.Article

SKELETAL MUSCLE SPASM AND A REVIEW OF MUSCLE RELAXANTSDE LEE JC; ROCKWOOD CA.1980; CURR. THERAPEUT. RES.; USA; DA. 1980; VOL. 27; NO 1; PP. 64-74; BIBL. 28 REF.Article

Synthèse et étude physicochimique de carbamates comme prodrogues du paracétamol et de la chlorzoxazone = Synthesis and physicochemical study of carbamates as prodrugs of paracetamol and chlorzoxazoneVigroux, Alain; Bergon, Michel.1992, 130 p.Thesis

Contribution of human CYP3A subfamily member to the 6-hydroxylation of chlorzoxazoneGORSKIT, J. C; JONES, D. R; WRIGHTON, S. A et al.Xenobiotica (London. Print). 1997, Vol 27, Num 3, pp 243-256, issn 0049-8254Article

FLUOROMETRIC DETERMINATION OF CHLORZOXAZONE VIA CHEMICAL DERIVATIZATIONSTEWART JT; CHAN CW.1978; ANAL. LETTERS; USA; DA. 1978; VOL. B11; NO 9; PP. 667-680; BIBL. 17 REF.Article

PHARMACOCINETIQUE DES INTERACTIONS MEDICAMENTEUSES: EFFET DE LA ZOXAZOLAMINE SUR LA COURBE DU TAUX PLASMATIQUE DANS LE TEMPS DE LA CHLORZOXAZONESAKIYA Y; AWAZU S; HANANO M et al.1974; YAKUGAKU ZASSHI, J. PHARM. SOC. JAP.; JAP.; DA. 1974; VOL. 94; NO 10; PP. 1307-1311; ABS. ANGL.; BIBL. 10REF.Article

A DOUBLE-BLIND EVALUATION OF PARAFON FORTE IN THE TREATMENT OF MUSCULO-SKELETAL BACK CONDITIONS = UNE ETUDE EN DOUBLE INSU DU PARAFON FORT DANS LE TRAITEMENT DES DOULEURS DORSALES MUSCULO-SQUELETTIQUESVERNON WG.1972; CURR. THERAPEUT. RES.; U.S.A.; DA. 1972; VOL. 14; NO 12; PP. 801-806; BIBL. 2REF.Serial Issue

Effects of nicotine on cytochrome P450 2A6 and 2E1 activitiesHUKKANEN, Janne; JACOB, Peyton; PENG, Margaret et al.British journal of clinical pharmacology. 2010, Vol 69, Num 2, pp 152-159, issn 0306-5251, 8 p.Article

Effects of steady-state lasofoxifene on CYP2D6- and CYP2E1 -mediated metabolismMOLLER, Robert A; FISHER, Jeannine M; TAYLOR, Ann E et al.The Annals of pharmacotherapy. 2006, Vol 40, Num 1, pp 32-37, issn 1060-0280, 6 p.Article

Robustness of chlorzoxazone as an in vivo measure of cytochrome P450 2E1 activityERNSTGARD, Lena; WARHOLM, Margareta; JOHANSON, Gunnar et al.British journal of clinical pharmacology. 2004, Vol 58, Num 2, pp 190-200, issn 0306-5251, 11 p.Article

Comparison of chlorzoxazone one-sample methods to estimate CYP2E1 activity in humansKRAMER, Iza; DALHOFF, Kim; CLEMMESEN, Jens O et al.European journal of clinical pharmacology. 2003, Vol 59, Num 10, pp 775-778, issn 0031-6970, 4 p.Article

The effect of endotoxin administration on the pharmacokinetics of chlorzoxazone in humansPOLOYAC, S. M; TOSHEVA, R. T; GARDNER, B. M et al.Clinical pharmacology and therapeutics. 1999, Vol 66, Num 6, pp 554-562, issn 0009-9236Article

Obesity-induced increase of CYP2E1 activity and its effect on disposition kinetics of chlorzoxazone in Zucker ratsKHEMAWOOT, Phisit; YOKOGAWA, Koichi; SHIMADA, Tsutomu et al.Biochemical pharmacology. 2007, Vol 73, Num 1, pp 155-162, issn 0006-2952, 8 p.Article

Pharmacokinetics of intravenous chlorzoxazone in rats with dehydration and rehydration: Effects of food intakesKIM, Yu C; KIM, Yoon G; KIM, Eun J et al.Biopharmaceutics & drug disposition. 2003, Vol 24, Num 2, pp 53-61, issn 0142-2782, 9 p.Article

A COMPARATIVE STUDY OF PARAFON FORTE CERCLE TABLETS AND SOMA CERCLE COMPOUND IN THE TREATMENT OF PAINFUL SKELETAL MUSCLE CONDITIONSMILLER AR.1976; CURR. THERAPEUT. RES.; U.S.A.; DA. 1976; VOL. 19; NO 4; PP. 444-450; BIBL. 9 REF.Article

An improved synthesis of isotope labeled 6-hydroxychlorzoxazoneZHIGANG JIAN; RAY, Tapan; WU, Amy et al.Journal of labelled compounds & radiopharmaceuticals. 2006, Vol 49, Num 11, pp 979-984, issn 0362-4803, 6 p.Article

Stimulatory effects of chlorzoxazone, a centrally acting muscle relaxant, on large conductance calcium-activated potassium channels in pituitary GH₃ cellsLIU, Yen-Chin; LO, Yuk-Keung; WU, Sheng-Nan et al.Brain research. 2003, Vol 959, Num 1, pp 86-97, issn 0006-8993, 12 p.Article

Diabetes mellitus increases the in vivo activity of cytochrome P450 2EI in humansZAIQI WANG; HALL, Stephen D; MAYA, Juan F et al.British journal of clinical pharmacology. 2003, Vol 55, Num 1, pp 77-85, issn 0306-5251, 9 p.Article

LIQUID CHROMATOGRAPHY IN PHARMACEUTICAL ANALYSIS. XI. DETERMINATION OF MUSCLE RELAXANT-ANALGESIC MIXTURES USING REVERSED-PHASE AND ION-PAIR TECHNIQUESSTEWART JT; HONIGBERG IL; COLDREN JW et al.1979; J. PHARM. SCI.; USA; DA. 1979; VOL. 68; NO 1; PP. 32-36; BIBL. 10 REF.Article

Chlorzoxazone hepatotoxic reactions: an analysis of 21 identified or presumed casesPOWER, B. J; CATTAU, E. L. JR; ZIMMERMAN, H. J et al.Archives of internal medicine (1960). 1986, Vol 146, Num 6, pp 1183-1186, issn 0003-9926Article

Reversed-phase HPLC method for the estimation of acetaminophen, ibuprofen and chlorzoxazone in formulationsRAVISANKAR, S; VASUDEVAN, M; GANDHIMATHI, M et al.Talanta (Oxford). 1998, Vol 46, Num 6, pp 1577-1581, issn 0039-9140Article

Pharmacokinetic and pharmacodynamic assessment of a five-probe metabolic cocktail for CYPs 1A2, 3A4, 2C9, 2D6 and 2E1BLAKEY, G. E; LOCKTON, J. A; PERRETT, J et al.British journal of clinical pharmacology. 2004, Vol 57, Num 2, pp 162-169, issn 0306-5251, 8 p.Article